131 related articles for article (PubMed ID: 16329108)
1. Retinoic acid-induced CD38 expression in HL-60 myeloblastic leukemia cells regulates cell differentiation or viability depending on expression levels.
Lamkin TJ; Chin V; Varvayanis S; Smith JL; Sramkoski RM; Jacobberger JW; Yen A
J Cell Biochem; 2006 Apr; 97(6):1328-38. PubMed ID: 16329108
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid-induced blr1 expression requires RARalpha, RXR, and MAPK activation and uses ERK2 but not JNK/SAPK to accelerate cell differentiation.
Battle TE; Roberson MS; Zhang T; Varvayanis S; Yen A
Eur J Cell Biol; 2001 Jan; 80(1):59-67. PubMed ID: 11211936
[TBL] [Abstract][Full Text] [Related]
3. Involvement of retinoic acid receptor-alpha-mediated signaling pathway in induction of CD38 cell-surface antigen.
Mehta K; McQueen T; Manshouri T; Andreeff M; Collins S; Albitar M
Blood; 1997 May; 89(10):3607-14. PubMed ID: 9160665
[TBL] [Abstract][Full Text] [Related]
4. Transformation-defective polyoma middle T antigen mutants defective in PLCgamma, PI-3, or src kinase activation enhance ERK2 activation and promote retinoic acid-induced, cell differentiation like wild-type middle T.
Yen A; Cherington V; Schaffhausen B; Marks K; Varvayanis S
Exp Cell Res; 1999 May; 248(2):538-51. PubMed ID: 10222145
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
[TBL] [Abstract][Full Text] [Related]
6. c-Cbl interacts with CD38 and promotes retinoic acid-induced differentiation and G0 arrest of human myeloblastic leukemia cells.
Shen M; Yen A
Cancer Res; 2008 Nov; 68(21):8761-9. PubMed ID: 18974118
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid causes MEK-dependent RAF phosphorylation through RARalpha plus RXR activation in HL-60 cells.
Hong HY; Varvayanis S; Yen A
Differentiation; 2001 Aug; 68(1):55-66. PubMed ID: 11683493
[TBL] [Abstract][Full Text] [Related]
8. A retinoic acid receptor beta/gamma-selective prodrug (tazarotene) plus a retinoid X receptor ligand induces extracellular signal-regulated kinase activation, retinoblastoma hypophosphorylation, G0 arrest, and cell differentiation.
Yen A; Fenning R; Chandraratna R; Walker P; Varvayanis S
Mol Pharmacol; 2004 Dec; 66(6):1727-37. PubMed ID: 15383624
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest.
Yen A; Roberson MS; Varvayanis S; Lee AT
Cancer Res; 1998 Jul; 58(14):3163-72. PubMed ID: 9679985
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid induces expression of SLP-76: expression with c-FMS enhances ERK activation and retinoic acid-induced differentiation/G0 arrest of HL-60 cells.
Yen A; Varvayanis S; Smith JL; Lamkin TJ
Eur J Cell Biol; 2006 Feb; 85(2):117-32. PubMed ID: 16439309
[TBL] [Abstract][Full Text] [Related]
11. Induction of retinoic acid receptor-alpha by granulocyte macrophage colony-stimulating factor in human myeloid leukemia cell lines.
Shimizu T; Takeda K
Cancer Res; 2000 Aug; 60(16):4544-9. PubMed ID: 10969805
[TBL] [Abstract][Full Text] [Related]
12. Activation of retinoid receptors RAR alpha and RXR alpha induces differentiation and apoptosis, respectively, in HL-60 cells.
Mehta K; McQueen T; Neamati N; Collins S; Andreeff M
Cell Growth Differ; 1996 Feb; 7(2):179-86. PubMed ID: 8822201
[TBL] [Abstract][Full Text] [Related]
13. Polyomavirus small t antigen prevents retinoic acid-induced retinoblastoma protein hypophosphorylation and redirects retinoic acid-induced G0 arrest and differentiation to apoptosis.
Yen A; Placanica L; Bloom S; Varvayanis S
J Virol; 2001 Jun; 75(11):5302-14. PubMed ID: 11333911
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of all-trans-retinoic acid-induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells.
Fang Y; Zhou X; Lin M; Ying M; Luo P; Zhu D; Lou J; Yang B; He Q
Mol Carcinog; 2011 Jan; 50(1):24-35. PubMed ID: 20945414
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D3- and retinoic acid-induced monocytic differentiation: interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells.
Botling J; Oberg F; Törmä H; Tuohimaa P; Bläuer M; Nilsson K
Cell Growth Differ; 1996 Sep; 7(9):1239-49. PubMed ID: 8877104
[TBL] [Abstract][Full Text] [Related]
16. Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells.
Manfredini R; Trevisan F; Grande A; Tagliafico E; Montanari M; Lemoli R; Visani G; Tura S; Ferrari S; Ferrari S
Cancer Res; 1999 Aug; 59(15):3803-11. PubMed ID: 10446999
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide cooperates with retinoic acid and 1,25-dihydroxyvitamin D(3) to regulate cell differentiation and cell cycle arrest of human myeloblastic leukemia cells.
Shen M; Yen A
Oncology; 2009; 76(2):91-100. PubMed ID: 19127080
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid-induced growth arrest and differentiation: retinoic acid up-regulates CD32 (Fc gammaRII) expression, the ectopic expression of which retards the cell cycle.
Wightman J; Roberson MS; Lamkin TJ; Varvayanis S; Yen A
Mol Cancer Ther; 2002 May; 1(7):493-506. PubMed ID: 12479267
[TBL] [Abstract][Full Text] [Related]
19. A functionally active RARalpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines.
Grande A; Montanari M; Manfredini R; Tagliafico E; Zanocco-Marani T; Trevisan F; Ligabue G; Siena M; Ferrari S; Ferrari S
Cell Death Differ; 2001 Jan; 8(1):70-82. PubMed ID: 11313705
[TBL] [Abstract][Full Text] [Related]
20. Increasing c-FMS (CSF-1 receptor) expression decreases retinoic acid concentration needed to cause cell differentiation and retinoblastoma protein hypophosphorylation.
Yen A; Sturgill R; Varvayanis S
Cancer Res; 1997 May; 57(10):2020-8. PubMed ID: 9158000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
